Printer Friendly

Chemical disguises improve peptide drug.

Chemical disguises improve peptide drug

Some promising medications, if taken by mouth, get stopped by digestive juices or liver enzymes before they ever have a chance to do their work. Pharmacologists have now disguised one such drug, called a renin inhibitor, so that it can sneak into the bloodstream and pass through the liver intact.

Renin inhibitors block the production of a substance called angiotensin II, which can raise blood pressure. Clinical studies have shown that injections of renin inhibitors can lower high blood pressure, and recent findings suggest that high levels of renin may increase heart attack risk in people with moderate hypertension (SN: 4/20/91, p.245).

But daily injections are impractical as a routine treatment regimen, so researchers at Abbott Laboratories in North Chicago set out to develop an effective oral alternative. They now report successfully camouflaging renin inhibitors in two ways and testing several compounds using each strategy.

Standard renin inhibitors consist of peptides -- amino acid chains linked by amide bonds, which are particularly vulnerable to disruption by enzymes. In one approach, the Abbott team made a "nonpeptide" that acts as a renin inhibitor but escapes recognition by peptide-degrading enzymes. "There are no naturally occurring amino acids as part of the structure," Abbott pharmacologist Hollis Kleinert says.b "It's something that I think will be very useful for all sorts of medications."

In a second approach, the researchers made "dipeptides" -- two amino acids linked by an amide bond -- but they modified the bond so that enzymes wouldn't recognize it.

They then gave oral doses of these compounds to rats and tracked the drugs' survival in the body. About 20 percent of the renin inhibitor remained in active form after passing through the liver, they found. This "oral bioavailability" is double the amount considered necessary for the drug to work, Kleinert says, and four times greater than that achieved with oral administration of the standard form of the peptide.
COPYRIGHT 1991 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:renin inhibitors, used for lowering blood pressure
Author:Pennisi, Elizabeth
Publication:Science News
Date:Apr 27, 1991
Words:323
Previous Article:Enthusiasm for niacin waned, now waxes.
Next Article:Molecular octopi learn sticky tricks.
Topics:


Related Articles
Hypertension, heart disease and diuretics.
Blood enzyme foretells heart attack threat.
Hypertension 2001: Pearls for the Clinician. (Featured CME Topic: Hypertension).
Plot thickens for blood pressure drugs. (Biomedicine).
Improving antihypertensive therapy in patients with diabetic nephropathy.
Pregnancy risk from blood pressure drugs?
Antihypertensive whey protein concentrate hydrolysates find nutraceutical beverage applications.
Primary aldosteronism and secondary hyperparathyroidism of the vitamin D deficiency.
Rationale for combination therapy in hypertension management: focus on angiotensin receptor blockers and thiazide diuretics.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters